NCT05908786
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05908786
Title A Study Evaluating The Efficacy and Safety of Neoadjuvant Immunotherapy Combinations in Patients With Surgically Resectable Hepatocellular Carcinoma
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Hoffmann-La Roche
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | GBR | FRA | ESP | DEU | AUT

Facility Status City State Zip Country Details
University of Southern California (USC) Los Angeles California 90033 United States Details
University of California Los Angeles (UCLA) - Cancer Care - Santa Monica Santa Monica California 90404-2023 United States Details
Georgetown University Medical Center Washington D.C. District of Columbia 20007 United States Details
Columbia University Medical Center New York New York 10032 United States Details
UT Southwestern Medical Center Dallas Texas 75390-8813 United States Details
Klinikum Klagenfurt am Wörthersee Klagenfurt 9020 Austria Details
Department of Internal Medicine III AKH and Medical University of Vienna Vienna 1090 Austria Details
Centre Georges Francois Leclerc (CGFL) Dijon 21079 France Details
Gustave Roussy Villejuif 94800 France Details
University Essen Essen 45147 Germany Details
Universitaets Klinikum Frankfurt - Zentrum der Inneren Medizin Frankfurt 60596 Germany Details
Hospital Universitario Marques de Valdecilla Santander Cantabria 39008 Spain Details
Hospital Universitario Fundacion Jimenez Diaz. Madrid 28040 Spain Details
Imperial College London - Imperial Centre for Translational and Experimental Medicine (ICTEM) London United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field